Physician practice size and variations in treatments and outcomes: evidence from Medicare patients with AMI

Jonathan D Ketcham1, Laurence C Baker, Donna MacIsaac

  • 1School of Health Management and Policy, W.P. Carey School of Business, Arizona State University, Tempe, USA. ketcham@asu.edu

Insights

Patients treated by solo physicians for acute myocardial infarction (AMI) received less timely cardiac procedures and had higher mortality rates compared to those treated by larger practices. These findings highlight potential disparities in care based on physician practice size.

Area of Science:

  • Cardiology
  • Health Services Research
  • Healthcare Policy

Background:

  • Physician practice size is not well understood in relation to patient treatment and outcomes.
  • Variations in care delivery within hospitals may exist based on physician practice characteristics.

Purpose of the Study:

  • To investigate the association between attending physician practice size and the quality of care for Medicare patients diagnosed with acute myocardial infarction (AMI).

Main Methods:

  • Retrospective analysis of Medicare patient data.
  • Comparison of treatment patterns and outcomes for patients treated by solo physicians versus those in larger practices.
  • Statistical adjustment for patient and physician characteristics.

Main Results:

  • Patients treated by solo physicians were less likely to undergo timely cardiac catheterization and angioplasty (within 24 hours of admission).
  • Higher in-hospital mortality rates were observed for patients treated by solo physicians.
  • These disparities persisted after accounting for patient and physician factors.

Conclusions:

  • Solo physician practice size is associated with suboptimal care delivery for acute myocardial infarction (AMI) patients.
  • Solo practitioners may be less likely to adhere to established clinical guidelines for AMI management.
  • Findings suggest potential quality of care gaps linked to physician practice structure.

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...